Antipodes Partners LTD Certara, Inc. Transaction History
Antipodes Partners LTD
- $2.85 Billion
- Q4 2024
A detailed history of Antipodes Partners LTD transactions in Certara, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 5,442 shares of CERT stock, worth $77,221. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,442
Previous 1,786
204.7%
Holding current value
$77,221
Previous $20,000
185.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CERT
# of Institutions
238Shares Held
109MCall Options Held
16.5KPut Options Held
19.2K-
Black Rock Inc. New York, NY13.4MShares$190 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$176 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.94MShares$127 Million0.48% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.88MShares$112 Million0.02% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO6.21MShares$88.2 Million0.99% of portfolio
About Certara, Inc.
- Ticker CERT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 159,899,008
- Market Cap $2.27B
- Description
- Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...